[1]
O. A. Uyaroğlu, M. Ç. Sönmezer, G. Telli Dizman, N. Çalık Başaran, S. Karahan, and Ö. Uzun, “Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study”, Acta Medica, vol. 53, no. 1, pp. 73–82, Mar. 2022.